Corning Incorporated will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including those for high throughput screening (HTS) and ADME/toxicology at the upcoming Society for Laboratory Automation and Screening (SLAS) conference, held February 2-6 in Washington, D.C.
Topics will include how the use of physiologically relevant 3D cell cultures is facilitating discovery and validation of novel drug targets and accelerating clinical translation of drug candidate screening for safety and efficacy. Spokespeople will be available for tours and to share insights at booth #413.
The company will highlight expanded product offerings, including the unique 1536-well plate designed specifically for spheroid HTS, and other 3D applications in oncology, neuroscience, toxicity screening, and more at exhibit #413. Corning will be able to speak to these applications, the impact of 3D in R&D and drug discovery, as well as perspectives in disease modeling and high-throughput screening.
Corning and its customers will also have several presentations and posters during SLAS including:
Presentations and Tutorials
Sunday, February 3, 2019
Short Course: Set-up and Validation of 3D Primary, Stem Cell and Immortalized Cultures for Downstream Microplate Reader and Imaging Applications
Presented by: Brad Larson, BioTek Instruments, Inc., Mark E. Rothenberg Ph.D., Corning Life Sciences
8:00 a.m. – 12:00 p.m.
Convention Center, room: 143C
Monday, February 4, 2019
Tutorial: Spheroids and Mini Brains for Studying Glioblastoma
2:00 – 2:45 p.m.
Presented by: Amanda Linkous, Ph.D., NCI Center for Systems Biology of Small Cell Lung Cancer at Vanderbilt, Hilary Sherman, Corning Life Sciences
Convention Center, Room 151A
Tuesday, February 5, 2019
Podium Presentation: Fully Automated Large Scale uHTS using 3D Cancer Organoid Models for Phenotypic Drug Discovery Applications
Presented by: Virneliz Fernandez Vega, Scripps Research Institute
12:00 – 12:30 p.m.
Wednesday, February 6, 2019
Podium Presentation by: High-throughput, CRISPR Based 3D Screening Platform for Rapid Discovery of Novel CDK4/6 Inhibitor Resistance
Presented by: Taraka Sai Pavan Grandhi, Ph.D, Genomics Institute of Novartis Research Foundation
11:00 AM - 11:30 AM
Corning Life Sciences and its customers will be presenting several posters throughout the meeting including those focused on high-throughput screening, 3D assay development, air-liquid interface models and other 3D application areas.